Flerie AB Cuts NAV by SEK 2.66/Share After Empros Write-Down
Flerie AB (publ) wrote down its holding in Empros Pharma, reducing Flerie’s NAV by SEK 2.66 per share, citing limited likelihood of value realization.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.